about
Progestogens or progestogen-releasing intrauterine systems for uterine fibroidsProgestogens or progestogen-releasing intrauterine systems for uterine fibroidsSelf-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women.The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapyRelationship between arsenic skin lesions and the age of natural menopause.Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the Sister StudyThe selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells.Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.Early-life exposures and early-onset uterine leiomyomata in black women in the Sister Study.Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for TherapyCirculating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids.Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid CellsEstrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.Oestrogen-induced angiogenesis and implantation contribute to the development of parasitic myomas after laparoscopic morcellationA low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cellsProgesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian womenReproductive tract function and dysfunction in women.Uterine leiomyomas: effects on architectural, cellular, and molecular determinants of endometrial receptivity.Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/β-Catenin Signaling Pathway.Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for MED12 exon 2 mutations.Single or repeated gonadotropin-releasing hormone agonist treatment avoids hysterectomy in premenopausal women with large symptomatic fibroids with no effects on sexual function.The relationship between urogenital symptoms and climacteric complaints.Effects of noncavity-distorting fibroids on endometrial gene expression and function.A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.Differential DNA Hydroxymethylation in Human Uterine Leiomyoma Cells Depending on the Phase of Menstrual Cycle and Presence of MED12 Gene Mutations.Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.Differential expression of visfatin, leptin, stromal cell derived factor-1α, endothelial nitric oxide synthase, and vascular endothelial growth factor in human leiomyomas.Comparison of antiresorptive effect of hormone therapy and ibandronate in postmenopausal osteoporotic women by assessing type I collagen C-telopeptide levels.
P2860
Q24200693-037937CB-87C6-474F-87EF-D724CD45562EQ24234601-2637DB5D-0159-4FA7-B961-322941258923Q27307658-C7F6F717-197C-4398-A845-CC314A5B5D46Q29040166-F60F4EFC-7449-4BEF-90CB-E54230031983Q33685214-E0ACBE06-B090-4900-B503-52E892505665Q33789925-92F48DF0-9490-4932-853C-74F189A4AB43Q33857422-7883DB06-308F-4CAE-893A-395EAA9ABC1CQ33964731-FA7BAAB9-DB7D-4723-B245-99B1CD207FF4Q34125151-C5AE8C80-710C-41F7-8AD8-68E76831E3BEQ34737702-6B8874EE-AD1C-4BBB-AC13-14C9FCCDBC70Q35328276-18B9F9ED-8CC0-4932-A5BD-C5B5A7B4EE81Q35441965-E9FAB283-2564-4367-B579-D9017A76C01AQ35807788-01608C3A-7E2F-445B-829C-FB22F8FCCE5FQ35855640-E68E758F-1896-4B5C-A317-126A8DCAA8F1Q36431640-CBCE20F4-CCDD-48B0-8A15-3850F6AD0F89Q36789291-5BABD358-71FC-424B-B0B6-0711543707F3Q36935561-77115387-65DC-455C-A91C-FF8DFA2649D6Q37219326-E25E4BE9-1DEF-46EE-8B72-FA1E943BAE12Q37316692-E076D008-E419-489D-BF96-0C8FF4475F78Q37323351-34E5ECDB-EA9F-4C02-88AF-E2CBB60018AAQ37417453-FAC3ABB8-65A9-45F3-AE7A-98F7A1596DC0Q37689995-517DC7CF-7C26-43F3-9D89-007AC1361984Q37879446-4A7E69A9-64D1-4000-B19D-116BF1506943Q38061520-D7DABA82-3DAB-4905-8C4B-14FAE47320D2Q38726268-C8E792AE-AEA3-45A8-8BD3-9D0547DE4EB8Q38792320-6237B1BE-8CBD-41B4-9DCA-169549751B87Q39524444-958D3FAF-0918-42AF-A788-2469D0E775CDQ43580545-5B1911BB-91D4-4B61-98D6-F81224F5C8A3Q44961483-A84B57F5-7A1D-4764-A6B4-6CC9139114D0Q46019835-3AB5A0C2-DDE0-4D3D-9C97-0F4E714773B4Q47119285-D27771C7-97FD-461F-9901-AF0AD7424891Q49861086-B713C76F-265F-409C-B6D2-A779AFD6B616Q50951938-92886898-5A64-40BD-A2E3-2B1E89761928Q50992850-D15C54B5-D6CD-40F0-A5FC-ED9D30B512ADQ55058946-517DC176-1AC4-4BD1-8B93-AE2F64FAC3B3
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Steroid hormones and leiomyomas.
@ast
Steroid hormones and leiomyomas.
@en
type
label
Steroid hormones and leiomyomas.
@ast
Steroid hormones and leiomyomas.
@en
prefLabel
Steroid hormones and leiomyomas.
@ast
Steroid hormones and leiomyomas.
@en
P1476
Steroid hormones and leiomyomas.
@en
P2093
Erica E Marsh
Serdar E Bulun
P356
10.1016/J.OGC.2005.12.001
P577
2006-03-01T00:00:00Z